Intelligence and Insights

This document outlines a replicable methodology for analyzing economic sectors in Jordan, focusing on the role and development potential of micro, small, and medium enterprises (MSMEs). Sector analyses in any country will vary in terms of...

This study aims to assess Jordan's existing trade-oriented services market and identify demand-driven trade-related services. The study employed desk research, expert interviews, and a survey conducted from September to November 2018. The...

This study contains the results of an unprecedented investigation into the nature of turnover in the Jordanian context, which is a necessary input for the process of promoting sustainable jobs. While reports from individuals and companies...

Turnover is a global phenomenon that can affect customer service and quality and eventually increase the risk of damaging long-term customer relations and losing contracts (Curtis & Wright, 2001). According to Catalyst (2018), the global...

The GIZ Employment-Oriented MSME Promotion Project (GIZ-MSME) aims to support Jordanian micro, small, and medium enterprises (MSMEs) in line with national strategies by focusing on food processing, among others, as a sector with...

This report presents a review of current issues in the pharmaceutical sector in Jordan. It examines the government's role (drug policy, regulations, pricing), the value chain (sourcing, R&D, production, packaging, storage, distribution),...

The present study provides a comprehensive analysis of the Jordanian chemical industry's current functioning and potential prospects, using a value chain perspective to determine activities subject to process optimization and identify key...

Given the strong reliance on imports, the pharmaceuticals market faced a decline in value and volume in 2016 at 14.6% and 1.6% negative CAGRs, respectively. This was mainly due to the currency depreciation, which impacted the purchasing...

The commercial drugs market grew by 11% in volume, driven mainly by the increase in domestic production of generic and cheaper drugs. The market grew by 51% in Russian Rouble terms but suffered a drop of 17% in USD value terms due to the...